ArticleWorld journal of urology2025
Endoscopic Combined Intra Renal Surgery versus Percutanous Nephrolithotomy: utcomes of a matched case-control analyis.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An Updated Systematic Review, Meta-analysis, and Trial Sequential Analysis of Endoscopic Combined Intrarenal Surgery (ECIRS) versus Percutaneous Nephrolithotomy (PCNL) for Upper Urinary Tract Calculi.European urology open science · 2026Review
- Use of Novel 6.3 Fr Ureteroscope in Endoscopic Combined Intrarenal Surgery (ECIRS): Comparative Experience with Conventional Ureteroscopes.Journal of clinical medicine · 2026Article
- Simultaneous Mini-ECIRS and low-energy TFL endopyelotomy for recurrent UPJO with pelvic renal calculus: A case report.Urology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the efficacy and safety outcomes of Endoscopic Combined Intrarenal Surgery (ECIRS) and Percutaneous Nephrolithotomy (PCNL) in the treatment of kidney stones.
methodsA retrospective matched case-control study was conducted from July 2022 to January 2024, utilizing prospectively collected kidney stone databases from two centers. Patients who underwent PCNL or ECIRS for kidney stone treatment were included. Cases and controls were matched based on stone complexity, using the Guy's Stone Score (GSS) in a 1:2 ratio. Computed tomography (CT) was performed 90 days postoperatively to assess the stone free rate, defined as the absence of residual fragments. The analyzed variables included age, sex, body mass index (BMI), ASA score, comorbidities, stone diameter, GSS, operative time, number of accesses, blood transfusions, hemoglobin drop, hospital stay, stone free rate, and complication rates. Statistical analysis was performed using the Student's t-test for continuous variables and the Chi-square or Fisher's exact test for categorical variables, with significance set at p < 0.05.
resultsA total of 165 patients were included (55 in the ECIRS group and 110 in the PCNL group). Demographic characteristics were comparable between groups. ECIRS demonstrated a higher stone-free rate (81.8% vs. 56.4%; p = 0.001), particularly in complex cases (GSS 3 and 4) (79.2% vs. 41.7%; p = 0.003). There was no significant difference in complication rates between the two groups (21.8% vs. 26.4%; p = 0.607).
conclusionECIRS is an effective treatment, particularly for large and complex kidney stones, offering higher success rates compared to PCNL, with similar complication rates.
Indexed as
Identifiers
40327141What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.